Provided by Tiger Trade Technology Pte. Ltd.

CervoMed

2.57
+0.09003.63%
Post-market: 2.640.0700+2.72%17:14 EDT
Volume:233.69K
Turnover:598.84K
Market Cap:38.86M
PE:-0.80
High:2.64
Open:2.54
Low:2.50
Close:2.48
52wk High:10.00
52wk Low:2.13
Shares:15.12M
Float Shares:9.60M
Volume Ratio:1.20
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1959
EPS(LYR):-2.9824
ROE:-107.62%
ROA:-60.80%
PB:1.69
PE(LYR):-0.86

Loading ...

CervoMed advances neflamapimod strategy with new DLB data

TIPRANKS
·
Jul 15

Cervomed Reports New Phase 2b Data Supporting Neflamapimod 50 Mg TID Dose for Planned DLB Phase 3 Trial

Reuters
·
Jul 14

Cervomed Announces New Clinical, Plasma Biomarker and Imaging Data at Aaic 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (dlb)

THOMSON REUTERS
·
Jul 14

Cervomed Price Target Maintained with a $25.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 13

Cervomed Price Target Maintained with a $25.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 09

CervoMed completes enrollment in neflamapimod study

TIPRANKS
·
Jul 09

Cervomed Completes Enrollment in Phase 2a Neflamapimod Trial for Nonfluent PPA

Reuters
·
Jul 09

Cervomed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia

THOMSON REUTERS
·
Jul 09

Cervomed - Interim Biomarker Data from Nfvppa Trial Expected Early Q4 2026

THOMSON REUTERS
·
Jul 09

CervoMed’s DLB Trial Milestone: What CRVO Investors Should Watch Next

TIPRANKS
·
Jul 09

CervoMed Files for Resale of Common Shares

MT Newswires Live
·
Jul 07

CervoMed registers to sell 10.08M shares of common stock for holders

TIPRANKS
·
Jul 07

Cervomed - Files to Register Resale of 10.08 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
Jul 07

Cervomed to Present New Neflamapimod Phase 2 Data in Lewy Body Dementia at AAIC 2026

Reuters
·
Jul 06

CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026

GlobeNewswire
·
Jul 06

H.C. Wainwright Keeps Their Buy Rating on CervoMed (CRVO)

TIPRANKS
·
Jun 25

CervoMed Closes $10 Million Stock Offering

MT Newswires Live
·
Jun 23

CervoMed Raises $10 Million in Direct Offering

TIPRANKS
·
Jun 23

CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Jun 23

CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Jun 23